United States · Wires & real time · GlobeNewswire
Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-November
Read the full article on GlobeNewswire Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

